US Equity
LPCN
— LIPOCINE INCLipocine Inc. is a clinical-stage biopharmaceutical company developing oral drug delivery solutions for metabolic and endocrine disorders.
💰 Market cap: $17.64M📍 675 S Arapeen Dr Ste 202, SALT LAKE CITY, UT, 84108-1295 US🏷️ Biotechnology & Medical Research💵 Previous close: $2.08🔢 3,230 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $2.08 |
| 2026-07-23 | $2.19 |
| 2026-07-22 | $2.23 |
| 2026-07-21 | $2.19 |
| 2026-07-20 | $2.15 |
| 2026-07-17 | $2.23 |
| 2026-07-16 | $2.29 |
| 2026-07-15 | $2.36 |
| 2026-07-14 | $2.31 |
| 2026-07-13 | $2.35 |
| 2026-07-10 | $2.41 |
| 2026-07-09 | $2.47 |
| 2026-07-08 | $2.44 |
| 2026-07-07 | $2.47 |
| 2026-07-06 | $2.47 |
| 2026-07-02 | $2.39 |
| 2026-07-01 | $2.46 |
| 2026-06-30 | $2.56 |
| 2026-06-29 | $2.49 |
| 2026-06-26 | $2.46 |
| 2026-06-25 | $2.38 |
| 2026-06-24 | $2.47 |
| 2026-06-23 | $2.53 |
| 2026-06-22 | $2.29 |
| 2026-06-18 | $2.33 |
| 2026-06-17 | $2.34 |
| 2026-06-16 | $2.30 |
| 2026-06-15 | $2.29 |
| 2026-06-12 | $2.26 |
| 2026-06-11 | $2.20 |
| 2026-06-10 | $1.98 |
| 2026-06-09 | $2.05 |
| 2026-06-08 | $2.04 |
| 2026-06-05 | $2.05 |
| 2026-06-04 | $2.21 |
| 2026-06-03 | $2.19 |
| 2026-06-02 | $2.25 |
| 2026-06-01 | $2.28 |
| 2026-05-29 | $2.25 |
| 2026-05-28 | $2.26 |
| 2026-05-27 | $2.28 |
| 2026-05-26 | $2.26 |
| 2026-05-22 | $2.26 |
| 2026-05-21 | $2.22 |
| 2026-05-20 | $2.24 |
| 2026-05-19 | $2.20 |
| 2026-05-18 | $2.21 |
| 2026-05-15 | $2.26 |
| 2026-05-14 | $2.33 |
| 2026-05-13 | $2.32 |
| 2026-05-12 | $2.33 |
| 2026-05-11 | $2.32 |
| 2026-05-08 | $2.37 |
| 2026-05-07 | $2.39 |
| 2026-05-06 | $2.43 |
| 2026-05-05 | $2.33 |
| 2026-05-04 | $2.29 |
| 2026-05-01 | $2.33 |
| 2026-04-30 | $2.33 |
| 2026-04-29 | $2.29 |
| 2026-04-28 | $2.31 |